State Stem Cell Agency ICOC Agenda 01-30-09

Return to CIRM Meetings and Events

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

 

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

Open Session

  1. Call to Order.
  2. Pledge of Allegiance.
  3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.] 

Action ITEMS

  1. Consideration of recommendations from Grants Working Group on Bridges to Stem Cell Research and Training Grant II applications.
    1. Extraordinary Petition: Training Program II Application TG2-01167
  2. Consideration of recommendations from Grants Working Group on Tools & Technology applications.
    1. 1. Extraordinary Petition: Tools & Technology Awards Application RT1-01073-1

Closed Session

  1.  
    1. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Bridges to Stem Cell Research, Training Grant II, and Tools and Technology applications. (Health & Safety Code 125290.30(d) (3) (B) and (C)).
    2. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)). 

ACTION ITEMS

  1. Public report of any action taken, if necessary, during closed session. 

Reports

  1. Presentation on CIRM collaborative funding policy. 

ACTION ITEMS

  1. Consideration of policies and implementation plan/processes for CIRM loan program, including but not limited to the Loan Administration Policy and the role of delegated underwriters/financial service providers.
    1. Response to RFI from Orix
    2. Draft Timeline from Orix
    3. Response to RFI from SVB
 10. Consideration of loan-related terms for Disease Teams RFA.
 11. Consideration of new scientific members for Grants Working Group.
 12. Consideration of a public process for obtaining Board member, industry and public input regarding an update to the Scientific Strategic Plan.
 13. Consideration of regulatory amendments to the CIRM Medical and Ethical Standards regulations, including oversight and consent requirements for use of blastocysts and somatic cells.

  1. Revision Key for MES Amendments
  2. Regulation 100070
  3. Regulation 100090
 14.

Consideration of supplemental grant awards for medical school loan repayments to those physician scientists who were awarded New Faculty I and II research grants. 

 

DISCUSSION ITEMS

Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE. Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 

Transcripts


Date Published: March 23, 2009
Last Modified: April 5, 2017